Joseph Géczy

472 total citations
29 papers, 373 citations indexed

About

Joseph Géczy is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Joseph Géczy has authored 29 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 9 papers in Psychiatry and Mental health and 8 papers in Pharmacology. Recurrent topics in Joseph Géczy's work include Neuroscience and Neuropharmacology Research (5 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Schizophrenia research and treatment (5 papers). Joseph Géczy is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Schizophrenia research and treatment (5 papers). Joseph Géczy collaborates with scholars based in Belgium, United States and Hungary. Joseph Géczy's co-authors include Jacques Bruhwyler, Jean‐François Liégeois, J. Delarge, J. P. Famaey, J. Damas, R Messin, Claude Dubois, Attilio Ceccato, Bernard Masereel and Jacques Crommen and has published in prestigious journals such as Biological Psychiatry, Journal of Medicinal Chemistry and Archives of Biochemistry and Biophysics.

In The Last Decade

Joseph Géczy

28 papers receiving 351 citations

Peers

Countries citing papers authored by Joseph Géczy

Since Specialization

Citations

This map shows the geographic impact of Joseph Géczy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Géczy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Géczy more than expected).

Fields of papers citing papers by Joseph Géczy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Géczy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Géczy. The network helps show where Joseph Géczy may publish in the future.

Co-authorship network of co-authors of Joseph Géczy

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Géczy. A scholar is included among the top collaborators of Joseph Géczy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Géczy. Joseph Géczy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tolerability to 1-year treatment with once-daily molsidomine in patients with stable angina 2006 ·Advances in Therapy ·R Messin, Jacques Bruhwyler, Claude Dubois, J. P. Famaey, Joseph Géczy	4
2	Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: Double-blind and open-label studies 2006 ·Advances in Therapy ·R Messin, (unknown), Claude Dubois, J. P. Famaey, Joseph Géczy	6
3	Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina 2005 ·Atherosclerosis ·(unknown), (unknown), Joseph Géczy, Arnold G. Herman	17
4	Age-Dependent Therapeutic Effects of Once-Daily Molsidomine Used as an Add-On Treatment in Patients with Stable Angina pectoris 2004 ·R Messin, (unknown), Claude Dubois, J. P. Famaey, Joseph Géczy	3
5	Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris 2004 ·International Journal of Cardiology ·R Messin, Grzegorz Opolski, (unknown), (unknown), Claude Dubois, J. P. Famaey, Joseph Géczy	28
6	Automated determination of pirlindole enantiomers in plasma by on-line coupling of a pre-column packed with restricted access material to a chiral liquid chromatographic column 2002 ·Journal of Pharmaceutical and Biomedical Analysis ·Patrice Chiap, Attilio Ceccato, Robert W. Góra, Ph. Hubert, Joseph Géczy, Jacques Crommen	19
7	The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates 2001 ·Psychopharmacology ·Daniel E. Casey, Jacques Bruhwyler, J. Delarge, Joseph Géczy, (unknown)	11
8	Novel inhibitors of the sodium–calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivatives 2001 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Françoise Van Eylen, (unknown), (unknown), Jean‐François Liégeois, Joseph Géczy, André Herchuelz, J. Delarge, Bernard Masereel	34
9	The inclusion of fluoxetine into γ-cyclodextrin increases its bioavailability: behavioural, electrophysiological and pharmacokinetic studies 2000 ·Psychopharmacology ·Joseph Géczy, Jacques Bruhwyler, Jacqueline Scuvée‐Moreau, Vincent Seutin, H. Masset, (unknown), A Dresse, (unknown), Emmanuel Decamp, Lajos Szente, J. Szejtli, Jean‐François Liégeois	19
10	Effects of JL 3, a putative antidepressant, on rat noradrenergic and serotonergic systems 1999 ·European Journal of Pharmacology ·Jean‐François Liégeois, Vincent Seutin, Jacqueline Scuvée‐Moreau, A Dresse, Jacques Bruhwyler, Joseph Géczy, J. Delarge, J. Damas	2
11	Oxidation Sensitivity May Be a Useful Tool for the Detection of the Hematotoxic Potential of Newly Developed Molecules: Application to Antipsychotic Drugs 1999 ·Archives of Biochemistry and Biophysics ·(unknown), Jacques Bruhwyler, Christine Petit, J. Damas, J. Delarge, Joseph Géczy, Jean‐Michel Kauffmann, Maurice Lamy, Herbert Y. Meltzer, Ange Mouithys‐Mickalad	13
12	Enantiomeric separation of pirlindole by liquid chromatography using different types of chiral stationary phases 1998 ·Journal of Pharmaceutical and Biomedical Analysis ·Attilio Ceccato, P. Hubert, Pascal De Tullio, Jean‐François Liégeois, (unknown), Joseph Géczy, Jacques Crommen	9
13	Simultaneous determination of pirlindole enantiomers and dehydropirlindole by chiral liquid chromatography 1998 ·Journal of Pharmaceutical and Biomedical Analysis ·Attilio Ceccato, Ph. Hubert, Pascal De Tullio, Jean‐François Liégeois, (unknown), Joseph Géczy, Jacques Crommen	7
14	Facilitatory effects of chronically administered citicoline on learning and memory processes in the dog 1998 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Jacques Bruhwyler, Jean‐François Liégeois, Joseph Géczy	16
15	Short- and Long-Term Effects of Molsidomine Retard and Molsidomine Nonretard on Exercise Capacity and Clinical Status in Patients with Stable Angina 1998 ·Journal of Cardiovascular Pharmacology ·R Messin, (unknown), (unknown), Jacques Bruhwyler, (unknown), (unknown), Joseph Géczy	9
16	JL13, A PYRIDOBENZOXAZEPINE COMPOUND WITH POTENTIAL ATYPICAL ANTIPSYCHOTIC ACTIVITY: A REVIEW OF ITS BEHAVIOURAL PROPERTIES 1997 ·Pharmacological Research ·Jacques Bruhwyler, Jean‐François Liégeois, J. BERGMAN, Galen Carey, Andrew J. Goudie, (unknown), Herbert Y. Meltzer, J. Delarge, Joseph Géczy	31
17	Double‐blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression 1997 ·Acta Psychiatrica Scandinavica ·(unknown), (unknown), (unknown), Bénédicte Brichard, Jacques Bruhwyler, Joseph Géczy	17
18	JL 13, a promising atypical antipsychotic: A review of its preclinical profile 1997 ·Biological Psychiatry ·Jean‐François Liégeois, Jacques Bruhwyler, J. Damas, J. Delarge, Joseph Géczy	1
19	A double‐blind randomized placebo‐controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression 1996 ·Acta Psychiatrica Scandinavica ·(unknown), (unknown), (unknown), Jacques Bruhwyler, Joseph Géczy	15
20	Dibenzoazepine analogues: the electrophysiological properties of JL3, a potential atypical antidepressant 1996 ·European Journal of Pharmacology ·(unknown), Jacqueline Scuvée‐Moreau, (unknown), J. Damas, Jacques Bruhwyler, Joseph Géczy, J. Delarge, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact